scientific advisory board

Myeloma Canada’s Board of Scientific Advisors is comprised of recognized Canadian leaders in the field of myeloma. The goals of the Board are to provide valuable counsel and support Myeloma Canada's mission to promote awareness, education and research for the Canadian myeloma community.

Members of the Scientific Advisory board of Myeloma Canada :

Nizar J Bahlis, MD

Tom Baker Cancer Center

Assistant Professor

University of Calgary

Foothills Medical Center

Calgary, AB

 

Andrew R Belch, MD (Chair)

Division of Medical Oncology

Department of Oncology

Cross Cancer Institute

University of Alberta

Edmonton, AB

 

Christine Chen, MD

Assistant Professor

Department of Medical

Oncology and Hematology

Princess Margaret Hospital

University Health Network

Toronto, ON

 

Richard LeBlanc, MD

Maisonneuve-Rosemont Hospital

Clinical Assistant Professor of Medicine,

University of Montreal

Montreal, QC

 

Ade Olujohungbe, MD

Associate Professor of Hematology

CancerCare Manitoba

Winnipeg, MB

 

Linda Pilarski, PhD

Division of Experimental Oncology

Department of Oncology

Cross Cancer Institute

University of Alberta

Edmonton, AB

Member, IMF Scientific Advisory Board

 

Donna E Reece, MD

Professor of Medicine

Director, Program for Multiple

Myeloma and Related Diseases

Department of Medical

Oncology and Hematology

Princess Margaret Hospital

University Health Network

Toronto, ON

Member, IMF Scientific Advisory Board

 

Tony Reiman, MD

Medical Oncologist

Atlantic Health Sciences

Corporation

Saint John Regional Hospital

Assistant Dean of Research

Dalhousie Medicine

New Brunswick

Saint John, NB

 

Jean Roy, MD

Maisonneuve-Rosemont Hospital

University of Montreal

Montreal, QC

 

Michael Sebag, MD, PhD

Assistant Professor,

McGill University Faculty of

Medicine,

McGill University Health Centre

Montreal, QC

 

Chaim Shustik, MD

Associate Professor of Medicine

& Oncology

McGill University Faculty

of Medicine

Royal Victoria Hospital

Montreal, QC

Member, IMF Scientific Advisory Board

 

Kevin J Song, MD

BC Cancer Research Centre

Vancouver General Hospital

Vancouver, BC

 

Rodger Tiedemann, PhD, ChB, MB

Scientist, Ontario Cancer Institute

Staff Hematologist

Multiple Myeloma and Lymphoma

Division of Medical Oncology &

Hematology

Princess Margaret Hospital

Assistant Professor of Medicine

Department of Medicine

Department of Medical Biophysics

University of Toronto

Toronto, ON

 

Suzanne Trudel, MD

Assistant Professor

Clinician/Research Scientist

Department of Medical Oncology and Hematology

Princess Margaret Hospital

University Health Network

Toronto, ON

 

Darrell White, MD

Nova Scotia Cancer Centre

Queen Elizabeth II Health

Services Centre

Dalhousie University

Halifax, NS